Online inquiry

IVTScrip™ mRNA-Anti-IL22, ILV-094(Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) (CAT#: GTTS-WQ8986MR)

This product GTTS-WQ8986MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP. It ecodes the monoclonal antibody that targets IL22 gene. The antibody can be applied in Inflammatory conditions research.

Specifications
Product type	mRNA
Modified bases	5-Methyl-CTP
5' Cap	Cap 1
Species	Homo sapiens
RefSeq	NM_020525.5
Applications	Gene therapy research
Format	Powder
Quantity	100 µg
Purification	oligo-dT affinity purification

Target Gene
Gene ID	50616
UniProt ID	Q9GZX6

Download
Download resources about mRNA therapeutics development to boost your research.

CUSTOMER REVIEWS and Q&As
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Anti-IL22, ILV-094(Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) (GTTS-WQ8986MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT	Product Name	Product Type	CDs
GTTS-WQ4853MR	IVTScrip™ mRNA-Anti-SDC1, BT-062(Cap 0, 2-Thio-UTP, 30 nt-poly(A))	mRNA	BT-062
GTTS-WQ641MR	IVTScrip™ mRNA-Anti-AOC3, 8c10(Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A))	mRNA	8c10
GTTS-WQ13594MR	IVTScrip™ mRNA-Anti-IL13, QAX-576(Cap 1, 5-Methyl-CTP, 30 nt-poly(A))	mRNA	QAX-576
GTTS-WQ976MR	IVTScrip™ mRNA-Anti-TNFRSF4, ABBV-368(Cap 0, Pseudo-UTP, 30 nt-poly(A))	mRNA	ABBV-368
GTTS-WQ11920MR	IVTScrip™ mRNA-Anti-GUCY2C, MLN2045(Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A))	mRNA	MLN2045
GTTS-WQ5133MR	IVTScrip™ mRNA-Anti-IL1RAP, CAN-04(Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A))	mRNA	CAN-04
GTTS-WQ7896MR	IVTScrip™ mRNA-Anti-MAG, GSK-249320(Cap 1, 2-Thio-UTP, 120 nt-poly(A))	mRNA	GSK-249320
GTTS-WQ8501MR	IVTScrip™ mRNA-Anti-ITGAL, hu1124(Cap 0, 2-Thio-UTP, 30 nt-poly(A))	mRNA	hu1124

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST